Results 181 to 190 of about 39,493 (235)

Micronutrients in polycystic ovary syndrome: molecular pathways, deficiencies, and therapeutic potential. [PDF]

Front Endocrinol (Lausanne)
Natarajan M, E SH, Nataraj R.
europepmc   +1 more source

Role of insulin-regulated aminopeptidase as potential biomarker in insulin resistant polycystic ovary syndrome patients. [PDF]

Arch Endocrinol Metab
Köse O, Gök K, Köse E, Gözükara SI, Tüten A, Bostancı MS.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Syndromes of Resistance to Thyroid Hormone*

Endocrine Reviews, 1993
I. Introduction THE syndromes of resistance to thyroid hormone are characterized by reduced clinical and biochemical manifestations of thyroid hormone action relative to the circulating hormone levels. In practice, most patients are identified by the persistent elevation of serum levels of T4 and T3 with “inappropriately” nonsuppressed TSH, in the ...
S, Refetoff, R E, Weiss, S J, Usala
openaire   +3 more sources

Syndromes of thyroid hormone resistance

Annales d'Endocrinologie, 2005
Thyroid hormone resistance (RTH) is a rare autosomal dominant disorder, characterized clinically by goiter and biochemically by elevated circulating free thyroid hormone levels in the presence of measurable serum TSH concentrations. About 85% of patients with RTH are harboring mutations in thyroid hormone receptor beta (TRB). These mutations cluster in
P. Beck-Peccoz, D. Mannavola, L.Persani
openaire   +3 more sources

Thyroid hormone resistance syndromes

The American Journal of Medicine, 1993
The thyroid hormone resistance syndromes are disorders in which the body's tissues are resistant to the effects of thyroid hormone. Generalized resistance to thyroid hormone (GRTH) is characterized by resistance in the pituitary gland and in most or all of the peripheral tissues.
M T, McDermott, E C, Ridgway
openaire   +2 more sources